📊 Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
-
- EPS Growth Range (1Y):
25-50%
- Net Income Growth Range (1Y):
25-50%
- Revenue Growth Range (1Y):
25-50%
-
Upcoming Earnings Date:
2026-02-26
💰 Dividend History
Current year to date yield:
0.00%
Amount: $0.000000
Yield: -
Pay Date: -
Details:
Ratio: 1:3
📅 SGX Earnings Announcements for 9QX
Beverly Wilshire Ltd. (9QX)
Market: SGX |
Currency: SGD
Address: 160 Robinson Road
Beverly Wilshire Ltd., an investment holding company, engages in the trading and distribution, and medical businesses in Singapore and Malaysia. The company operates through three segments: Trading and Distribution; Aesthetic Medical and Healthcare; and Investment and Others. The Trading and Distribution segment engages in the trading and distribution of steel raw materials, consumables, instruments, and semi-finished products for steel mills, iron and steel foundries, and aluminum smelters in the Asia-Pacific region, as well as provision of ancillary services. The Aesthetic Medical segment offers aesthetic medical services, including the provision of aesthetic medical, beauty, and wellness services. The Investment and Others segment provides management services, as well as marketing, distribution, and related services. The company provides plastic surgery, cosmetic and reconstructive surgery, aesthetic dental care, cosmetological and aesthetical related treatments, hair transplant, physiotherapy, spa, and reflexology services; healthy aging therapy, health screening and wellness, and medical research services; and operates medical specialist center with outpatient and day care services and activities. It also offers clinical and other general medical services, and beauty salons. The company was formerly known as Beverly JCG Ltd. and changed its name to Beverly Wilshire Ltd. in September 2025. Beverly Wilshire Ltd. was founded in 1987 and is headquartered in Singapore.
Show more
📈 Beverly Wilshire Ltd. Historical Chart
🧾 Recent Financial Statement Analysis
January 22, 2026
Beverly Wilshire Ltd. Receives SGX Listing and Quotation Notice for New Share Issuances – Key Investor Update Beverly Wilshire Ltd. Receives SGX Listing and Quotation Notice for New Share Issuances Key Points for Investors Beverly Wilshire Ltd. has received approval…
January 9, 2026
Beverly Wilshire Ltd. Announces Private Placement to Raise S\$125,000 through Share Subscription Beverly Wilshire Ltd. Announces Private Placement to Raise S\$125,000 through Share Subscription Key Highlights Private Placement of 12.14 Million New Shares: Beverly Wilshire Ltd. will issue 12,135,921 new…
January 9, 2026
Beverly Wilshire Ltd. Announces Debt Capitalisation via Share Issuance to Conserve Cash Beverly Wilshire Ltd. Announces Capitalisation of Outstanding Remuneration via Share Issuance Key Highlights Debt Capitalisation Agreement: Beverly Wilshire Ltd. has entered into an agreement with Cheah Sin Hing…
January 9, 2026
Beverly JCG Ltd. Announces Proposed Issuance of Shares to Evolve Capital Advisory Beverly JCG Ltd. Announces Proposed Issuance of Shares to Evolve Capital Advisory Private Limited Key Points for Investors Share Issuance Agreement: On 9 January 2026, Beverly JCG Ltd.…
December 17, 2025
Beverly Wilshire Ltd. Completes Consideration Share Issuance for Major Healthcare Asset Acquisition Beverly Wilshire Ltd. Completes Consideration Share Issuance for Major Healthcare Asset Acquisition Key Points from the Report Completion of Share Issuance: On 17 December 2025, Beverly Wilshire Ltd.…
November 21, 2025
Beverly Wilshire Ltd. Announces Private Placement of 5,000,000 New Shares Beverly Wilshire Ltd. Announces Private Placement of 5,000,000 New Shares to Tee Lay Yeong Beverly Wilshire Ltd. ("the Company"), a Singapore-incorporated entity, has announced a significant private placement transaction involving…
October 6, 2025
Beverly JCG Ltd. Shareholders Approve Major Acquisition, Issuance of Securities, and Name Change to Beverly Wilshire Ltd. – What Investors Must Know Beverly JCG Ltd. Shareholders Approve Major Acquisition, Issuance of Securities, and Name Change to Beverly Wilshire Ltd. –…
August 27, 2025
Beverly JCG Ltd. Announces New Share Placement to Private Investor: What Retail Shareholders Need to Know Beverly JCG Ltd. Announces S\$200,000 Share Subscription: A New Investor Joins, Financial Position Strengthened Key Highlights from the Announcement New Share Placement: Beverly JCG…
August 25, 2025
Beverly JCG Announces S\$200,000 Private Placement: What Retail Investors Must Know About the New Share Subscription Beverly JCG Announces S\$200,000 Private Placement: What Retail Investors Must Know About the New Share Subscription Key Points: Major Share Subscription, Shareholder Impact, and…
August 12, 2025
Beverly JCG Ltd. Q2 2025 Financial Report Analysis Beverly JCG Ltd., a Singapore-listed company focused on aesthetic medical, healthcare, and trading activities, has released its condensed interim consolidated financial statements for the second quarter and six months ended 30 June…
April 14, 2025
Financial Analysis Report: BEVERLY JCG LTD. Company Overview BEVERLY JCG LTD. is a company incorporated in the Republic of Singapore with a listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). The company operates in an unspecified industry. Business Description…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Related News & Research
Showing results matched by any of: 9QX, Beverly Wilshire Ltd., BeverlyJCG, JCGI SP, BEVERLY JCG LTD, BEVERLY JCG
January 22, 2026
Beverly Wilshire Ltd. Receives SGX Listing and Quotation Notice for New Share Issuances – Key Investor Update Beverly Wilshire Ltd. Receives SGX Listing and Quotation Notice for New Share Issuances Key Points for Investors Beverly Wilshire Ltd. has received approval…
January 9, 2026
Beverly Wilshire Ltd. Announces Private Placement to Raise S\$125,000 through Share Subscription Beverly Wilshire Ltd. Announces Private Placement to Raise S\$125,000 through Share Subscription Key Highlights Private Placement of 12.14 Million New Shares: Beverly Wilshire Ltd. will issue 12,135,921 new…
January 9, 2026
Beverly Wilshire Ltd. Announces Debt Capitalisation via Share Issuance to Conserve Cash Beverly Wilshire Ltd. Announces Capitalisation of Outstanding Remuneration via Share Issuance Key Highlights Debt Capitalisation Agreement: Beverly Wilshire Ltd. has entered into an agreement with Cheah Sin Hing…
January 9, 2026
Beverly JCG Ltd. Announces Proposed Issuance of Shares to Evolve Capital Advisory Beverly JCG Ltd. Announces Proposed Issuance of Shares to Evolve Capital Advisory Private Limited Key Points for Investors Share Issuance Agreement: On 9 January 2026, Beverly JCG Ltd.…
December 17, 2025
Beverly Wilshire Ltd. Completes Consideration Share Issuance for Major Healthcare Asset Acquisition Beverly Wilshire Ltd. Completes Consideration Share Issuance for Major Healthcare Asset Acquisition Key Points from the Report Completion of Share Issuance: On 17 December 2025, Beverly Wilshire Ltd.…
November 21, 2025
Beverly Wilshire Ltd. Announces Private Placement of 5,000,000 New Shares Beverly Wilshire Ltd. Announces Private Placement of 5,000,000 New Shares to Tee Lay Yeong Beverly Wilshire Ltd. ("the Company"), a Singapore-incorporated entity, has announced a significant private placement transaction involving…
November 19, 2025
Beverly Wilshire Ltd. Announces Completion of Strategic Share Issuances and Debt Capitalisation Beverly Wilshire Ltd. Announces Completion of Strategic Share Issuances and Debt Capitalisation Key Points for Investors Completion of Four Major Share Issuances to strategic investors and a key…
November 14, 2025
Beverly Wilshire Ltd. Receives Listing and Quotation Notice for Share Issuances and Acquisition Beverly Wilshire Ltd. Announces Receipt of SGX Listing and Quotation Notice for Multiple Share Issuances Key Points of the Announcement Beverly Wilshire Ltd. has received a Listing…
November 11, 2025
Beverly Wilshire Ltd. Q3 2025 Financial Review: A Turnaround in Progress Beverly Wilshire Ltd., a Singapore-listed company primarily engaged in aesthetic medical and healthcare services, has released its condensed interim consolidated financial statements for the third quarter and nine months…
October 8, 2025
Beverly Wilshire Announces S\$100,000 Private Placement: Key Details for Investors Beverly Wilshire Ltd. Launches S\$100,000 Private Placement to Strengthen Capital Base Key Points of the Announcement Private placement of 8,547,008 new ordinary shares at S\$0.0117 per share to raise S\$100,000.…
October 6, 2025
Beverly JCG Ltd. Shareholders Approve Major Acquisition, Issuance of Securities, and Name Change to Beverly Wilshire Ltd. – What Investors Must Know Beverly JCG Ltd. Shareholders Approve Major Acquisition, Issuance of Securities, and Name Change to Beverly Wilshire Ltd. –…
August 27, 2025
Beverly JCG Ltd. Announces New Share Placement to Private Investor: What Retail Shareholders Need to Know Beverly JCG Ltd. Announces S\$200,000 Share Subscription: A New Investor Joins, Financial Position Strengthened Key Highlights from the Announcement New Share Placement: Beverly JCG…
August 25, 2025
Beverly JCG Announces S\$200,000 Private Placement: What Retail Investors Must Know About the New Share Subscription Beverly JCG Announces S\$200,000 Private Placement: What Retail Investors Must Know About the New Share Subscription Key Points: Major Share Subscription, Shareholder Impact, and…
August 12, 2025
Beverly JCG Ltd. Q2 2025 Financial Report Analysis Beverly JCG Ltd., a Singapore-listed company focused on aesthetic medical, healthcare, and trading activities, has released its condensed interim consolidated financial statements for the second quarter and six months ended 30 June…
April 14, 2025
Financial Analysis Report: BEVERLY JCG LTD. Company Overview BEVERLY JCG LTD. is a company incorporated in the Republic of Singapore with a listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). The company operates in an unspecified industry. Business Description…
April 14, 2025
Financial Analysis Report: Beverly JCG Ltd. (Net Profit Decline) Company Overview Beverly JCG Ltd. is a Singapore-incorporated company with a presence in the aesthetic medical and healthcare segment in Malaysia. The company's core business operations include providing medical and healthcare…
March 30, 2025
Title: Substantial Shareholder Injects $500,000 into Beverly JCG Ltd. to Fuel Growth Key Points: Beverly JCG Ltd. has entered into a subscription agreement with its substantial shareholder, Mark Phillip Jones, to issue 57,471,264 new ordinary shares at $0.0087 per share,…
March 5, 2025
Discounted Share Subscription Shake-Up: Beverly JCG Ltd's Strategic Capital Injection Set to Impact Share Price Discounted Share Subscription Shake-Up: Beverly JCG Ltd's Strategic Capital Injection Set to Impact Share Price Beverly JCG Ltd has announced a notable capital-raising move that…
December 21, 2024
Beverly JCG Ltd. Announces S\$500,000 Share Subscription Boost Beverly JCG Ltd. Announces S\$500,000 Share Subscription Boost Beverly JCG Ltd., a company incorporated in the Republic of Singapore, has struck a subscription agreement to issue 61,728,395 new ordinary shares at S\$0.0081…
December 4, 2024
Beverly JCG Ltd. to Strengthen Capital Base with Strategic Share Subscription Beverly JCG Ltd. to Strengthen Capital Base with Strategic Share Subscription Beverly JCG Ltd., a company incorporated in Singapore, has announced a subscription agreement with investor Lim Beoy Kee.…
